Stakeholder Perceptions of Pentavalent Vaccine (DTwP-HepB-Hib) in the Uniject™ Injection System
This report discusses stakeholder attitudes towards pentavalent vaccine (which combines five antigens for protection against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type B) in the Uniject™ injection system. The authors conducted semi-structured interviews with 151 health care workers and policy and procurement officers from Bangladesh, Cambodia, Kenya, Peru, Senegal, and Uganda. The results showed that the concept of pentavalent vaccine prefilled in Uniject™ was well received across the different stakeholders.
Author: PATH, Peruvian Ministry of Health, World Health Organization
» Download file (English)
186 KB PDF (Located at www.path.org)
Diseases/vaccines: Not disease/vaccine specific